Hangzhou Ruidi Biotechnology Ltd. was founded in 2014 by scientists returning from the UK and the US.It is a national high-tech enterprise focusing on the pulsed electric field energy platform, dedicated to the innovation of high-end minimally invasive interventional medical devices, and promoting the biomedical translation and application of pulsed electric field technology.

Ruidi Biotech has currently laid out a number of product pipelines covering oncology, atrial fibrillation, chronic encephalopathy and other fields, all of which have entered the special approval channel for innovative medical devices.